여포성 종양에서 CXC Chemokine Receptor 4와 Galectin-3의 면역조직화학적 발현
Immunohistochemical Expression of CXC Chemokine Receptor 4 and Galectin-3 in Follicular Tumors of Thyroid
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Follicular tumors can present a difficult diagnostic challenge for cytological evaluation and ultrasound findings. Therefore, new methods which could help distinguish follicular adenoma from follicular carcinoma simply and accurately are greatly desired. This study investigated the usefulness of immnunohistochemical expression of CXC chemokine receptor 4 (CXCR4) and galectin-3 as marker of differentiated thyroid carcinomas. Materials and Methods: Expression of CXCR4 and galectin-3 were examined immunohistochemically in the 60 paraffin embedded tissues which were already diagnosed as follicular adenoma (n=20), follicullar carcinoma (n=20), and papillary carcinoma (n=20) of thyroid. Results: Galatin-3 was expressed significantly high in follicular carcinoma than follicular adenoma (p=0.022). CXCR4 was also expressed significantly high in follicular carcinoma than follicular adenoma (p=0.027). The sensitivity of CXCR4 and galectin-3 was 70% and 80% and specificity, 65% and 60% for differential diagnosis of follicular tumors. Conclusion: An immunohistochemical panel, including galatin-3 and CXCR4, could be useful in the differential diagnosis between follicular adenoma from follicular carcinoma.
Abstract
Background and Objectives: Follicular tumors can present a difficult diagnostic challenge for cytological evaluation and ultrasound findings. Therefore, new methods which could help distinguish follicular adenoma from follicular carcinoma simply and accurately are greatly desired. This study investigated the usefulness of immnunohistochemical expression of CXC chemokine receptor 4 (CXCR4) and galectin-3 as marker of differentiated thyroid carcinomas. Materials and Methods: Expression of CXCR4 and galectin-3 were examined immunohistochemically in the 60 paraffin embedded tissues which were already diagnosed as follicular adenoma (n=20), follicullar carcinoma (n=20), and papillary carcinoma (n=20) of thyroid. Results: Galatin-3 was expressed significantly high in follicular carcinoma than follicular adenoma (p=0.022). CXCR4 was also expressed significantly high in follicular carcinoma than follicular adenoma (p=0.027). The sensitivity of CXCR4 and galectin-3 was 70% and 80% and specificity, 65% and 60% for differential diagnosis of follicular tumors. Conclusion: An immunohistochemical panel, including galatin-3 and CXCR4, could be useful in the differential diagnosis between follicular adenoma from follicular carcinoma.
참고문헌 (29)
- Vander JB, "The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy", Ann Intern Med, 69(3), pp.537~540 (1968)
- Hegedus L, "Clinical practice. The thyroid nodule", N Engl J Med, 351(17), pp.1764~1771 (2004)
- Tan GH, "Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging", Ann Intern Med, 126(3), pp.226~231 (1997)
- Ezzat S, "Thyroid incidentalomas. Prevalence by palpation and ultrasonography", Arch Intern Med, 154(16), pp.1838~1840 (1994)
- Ross DS, "Nonpalpable thyroid nodules-managing an epidemic", J Clin Endocrinol Metab, 87(5), pp.1938~1940 (2002)
- Amrikachi M, "Accuracy of fine-needle aspiration of thyroid", Arch Pathol Lab Med, 125(4), pp.484~488 (2001)
- Gharib H, "Thyroid nodules: clinical importance, assessment, and treatment", Endocrinol Metab Clin North Am, 36(3), pp.707~735 (2007)
- Papini E, "Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87(5), pp.1941~1946 (2002)
- Kawachi K, "Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation", Hum Pathol, 31(4), pp.428~433 (2000)
- Choufani G, "The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers", Cancer, 86(11), pp.2353~2363 (1999)
- Perillo NL, "Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death", J Mol Med (Berl), 76(6), pp.402~412 (1998)
- Orlandi F, "Galectin-3 is a presurgical marker of human thyroid carcinoma", Cancer Res, 58(14), pp.3015~3020 (1998)
- Oestreicher-Kedem Y, "Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions", Head Neck, 26(11), pp.960~966 (2004)
- Saggiorato E, "Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application", Endocr Relat Cancer, 12(2), pp.305~317 (2005)
- 배규환, "갑상선 결절에서 Galectin-3 및 Thyroid Peroxidase의 발현", Endocrinology and Metabolism, 22(2), pp.105~111 (2007), 대한내분비학회
- Xu XC, "Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications", Am J Pathol, 147(3), pp.815~822 (1995)
- Fernandez PL, "Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue", J Pathol, 181(1), pp.80~86 (1997)
- Bartolazzi A, "Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions", Lancet, 357(9269), pp.1644~1650 (2001)
- Mehrotra P, "Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms", Histopathology, 45(5), pp.493~500 (2004)
- Kulbe H, "The chemokine network in cancer-much more than directing cell movement", Int J Dev Biol, 48(5-6), pp.489~496 (2004)
- Muller A, "Involvement of chemokine receptors in breast cancer metastasis", Nature, 410(6824), pp.50~56 (2001)
- Kim J, "Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival", J Clin Oncol, 23(12), pp.2744~2753 (2005)
- Mochizuki H, "Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis", Biochem Biophys Res Commun, 320(3), pp.656~663 (2004)
- Vandercappellen J, "The role of CXC chemokines and their receptors in cancer", Cancer Lett, 267(2), pp.226~244 (2008)
- wang JH, "CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells", J Clin Endocrinol Metab, 88(1), pp.408~416 (2003)
- De Falco V, "Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer", Cancer Res, 67(24), pp.11821~11829 (2007)
- Torregrossa L, "CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1", Thyroid, 20(5), pp.495~504 (2010)
- Castellone MD, "Functional expression of the CXCR4 chemokine receptor is induced by RET", PTC oncogenes and is a common event in human papillary thyroid carcinomas, 2004, pp.23(35), 5958~5967
- Wagner PL, "The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma", Ann Surg Oncol, 15(10), pp.2833~2841 (2008)